Drug Design and Discovery Methods and Protocols /
مؤلف مشترك: | |
---|---|
مؤلفون آخرون: | |
الملخص: | XI, 284 p. text |
اللغة: | الإنجليزية |
منشور في: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2011.
|
الطبعة: | 1st ed. 2011. |
سلاسل: | Methods in Molecular Biology,
716 |
الموضوعات: | |
الوصول للمادة أونلاين: | https://doi.org/10.1007/978-1-61779-012-6 |
التنسيق: | الكتروني كتاب الكتروني |
جدول المحتويات:
- Virtual Screening for Lead Discovery
- Computer-Aided Drug Discovery and Development
- Using Active Site Mapping and Receptor-Based Pharmacophore Tools: Prelude to Docking and De Novo/Fragment-Based Ligand Design
- Methods for Evaluation of Structural and Biological Properties of Anti-Invasive Natural Products
- Solid-Phase Peptide Synthesis Using Microwave Irradiation
- Fluorescent and Lanthanide Labeling for Ligand Screens, Assays, and Imaging
- DNA-Directed Assembly Microarray for Protein and Small Molecule Inhibitor Screening
- Selection of Peptide Ligands for Human Placental Transcytosis Systems Using In vitro Phage Display
- Optimization of the Tetrazolium Dye (MTT) Colorimetric Assay for Cellular Growth and Viability
- Imaging NF- κB Signaling in Mice for Screening Anti-Cancer Drugs
- Evaluation of Anticancer Agents Using Flow Cytometry Analysis of Cancer Stem Cells
- Chemical Screening with Zebrafish Embryos.- iTRAQTM Labeling Coupled with LC-MALDI Mass Spectrometry for Monitoring Temporal Response of Colorectal Cancer Cells to Butyrate Treatment
- Heterotypic Cell Adhesion Assay for the Study of Cell Adhesion Inhibition
- Evaluation of Antibacterial Activity of Proteins and Peptides Using a Specific Animal Model for Wound Healing
- In vitro Immunogenicity Risk Assessment of Therapeutic Proteins in Preclinical Setting.